Figure 4From: Assessing time to pulmonary function benefit following antibiotic treatment of acute cystic fibrosis exacerbations Average daily change in FEV 1 from baseline by treatment group. Gray circles, patients treated with ceftaz/tobra. Open circles, patients treated with mero/tobra. Sample sizes for measures are in parentheses.Back to article page